Cardiovascular Systems () Debt/EBITDA US GAAP (year values) |
||||||||
2020 | 2021 | 2022 | 2022 | LTM ? | ||||
Debt/EBITDA | 8.28 | 17.4 | 0.01 | 4.05 | 4.25 | |||
Changes by years, y/y, % | -93% | +110% | -100% | +79 931% |
Cardiovascular Systems. Debt/EBITDA
Cardiovascular Systems. Debt/EBITDA, changes, %
Cardiovascular Systems () Debt/EBITDA US GAAP (quarter values) |
||||||||
2022Q4 | 2022Q4 | 2023Q1 | 2023Q1 | 2023Q2 | LTM ? | |||
Debt/EBITDA | 0.00 | 3.29 | 0.01 | 3.30 | 2.47 | 4.25 | ||
Changes by years, y/y, % | -100% | -89% | -100% | -36% | ||||
Changes by quarters, q/q, % | -100% | +69 025% | -100% | +58 547% | -25% |